
Cumberland Pharmaceuticals Inc
CPIXNasdaqCIK 1087294HealthcareFiscal year ends Dec 31
Reports and events: 327 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2013-10-3118:45 ET | 8-K | 8.01 Other events | 0001087294-13-000013 |
| 2013-10-0717:31 ET | 8-K | 8.01 Other events | 0001445305-13-002363 |
| 2013-08-0917:13 ET | 8-K | 2.02 Results of operations | 0001087294-13-000011 |
| 2013-08-0917:07 ET | 10-Q | Quarterly reportPeriod 2013-06-30 | 0001087294-13-000009 |
| 2013-06-1416:50 ET | 8-K | 9.01 Financial statements and exhibits | 0001087294-13-000006 |
| 2013-06-0317:08 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001087294-13-000004 |
| 2013-05-0821:28 ET | 10-Q | Quarterly reportPeriod 2013-03-31 | 0001445305-13-001190 |
| 2013-05-0317:06 ET | 8-K | 2.02 Results of operations | 0001445305-13-001111 |
| 2013-04-1917:15 ET | 8-K | 5.07 Shareholder vote results | 0001445305-13-000850 |
| 2013-04-0816:08 ET | 8-K | 8.01 Other events | 0001445305-13-000792 |
| 2013-03-1416:31 ET | DEF 14A | Proxy statementPeriod 2013-04-16 | 0001445305-13-000615 |
| 2013-03-1217:04 ET | 10-K | Annual reportPeriod 2012-12-31 | 0001445305-13-000573 |
| 2013-03-0417:53 ET | 8-K | 2.02 Results of operations | 0001445305-13-000444 |
| 2013-02-2618:12 ET | 8-K | 8.01 Other events | 0001445305-13-000313 |
| 2013-02-2117:07 ET | 8-K | 8.01 Other events | 0001445305-13-000280 |
| 2013-02-0116:30 ET | 8-K | 8.01 Other events | 0001445305-13-000138 |
| 2013-01-1116:02 ET | 8-K | 8.01 Other events | 0001193125-13-010725 |
| 2012-11-3016:58 ET | 8-K | 2.05 Exit or disposal costs | 0001299933-12-002670 |
| 2012-11-1617:03 ET | 8-K | 8.01 Other events | 0001299933-12-002591 |
| 2012-11-1308:56 ET | 8-K | 8.01 Other events | 0001299933-12-002539 |
| 2012-11-0909:04 ET | 8-K | 8.01 Other events | 0001299933-12-002530 |
| 2012-11-0217:00 ET | 10-Q | Quarterly reportPeriod 2012-09-30 | 0001193125-12-449319 |
| 2012-11-0116:57 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001299933-12-002459 |
| 2012-09-1909:45 ET | 8-K | 8.01 Other events | 0001299933-12-002152 |
| 2012-08-0917:17 ET | 10-Q | Quarterly reportPeriod 2012-06-30 | 0001193125-12-347942 |
| 2012-08-0217:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001299933-12-001843 |
| 2012-06-2916:32 ET | 8-K | 8.01 Other events | 0001299933-12-001580 |
| 2012-05-2417:29 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-12-247355 |
| 2012-05-1816:39 ET | 8-K | 8.01 Other events | 0001299933-12-001245 |
| 2012-05-0417:18 ET | 10-Q | Quarterly reportPeriod 2012-03-31 | 0001193125-12-212336 |
| 2012-05-0317:24 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001299933-12-001083 |
| 2012-04-2016:14 ET | 8-K | 5.07 Shareholder vote results | 0001299933-12-000915 |
| 2012-04-1117:09 ET | 8-K | 8.01 Other events | 0001299933-12-000830 |
| 2012-03-1206:11 ET | DEF 14A | Proxy statementPeriod 2012-04-17 | 0001193125-12-107956 |
| 2012-03-0717:29 ET | 10-K | Annual reportPeriod 2011-12-31 | 0001193125-12-101478 |
| 2012-03-0116:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001299933-12-000531 |
| 2011-11-2218:25 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001299933-11-003397 |
| 2011-11-0717:01 ET | 10-Q | Quarterly reportPeriod 2011-09-30 | 0000950123-11-096010 |
| 2011-11-0317:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001299933-11-003222 |
| 2011-10-1817:43 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001299933-11-003050 |
| 2011-08-0817:15 ET | 10-Q | Quarterly reportPeriod 2011-06-30 | 0000950123-11-074496 |
| 2011-08-0510:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001299933-11-002430 |
| 2011-06-2413:02 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950123-11-061495 |
| 2011-05-0917:19 ET | 10-Q | Quarterly reportPeriod 2011-03-31 | 0000950123-11-047522 |
| 2011-05-0516:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001299933-11-001360 |
| 2011-04-2017:39 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001299933-11-001144 |
| 2011-04-0417:28 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001299933-11-001001 |
| 2011-03-1418:45 ET | DEF 14A | Proxy statementPeriod 2011-04-19 | 0000950123-11-024911 |
| 2011-03-1117:19 ET | 10-K | Annual reportPeriod 2010-12-31 | 0000950123-11-024871 |
| 2011-03-0911:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001299933-11-000759 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 23:39 ET. Listed shows no prices and gives no investment advice.